Jump to content

Talk:Ellipta

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia


Trelegy Ellipta

[edit]

According to:

"Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US" (Press release). GlaxoSmithKline. 18 September 2017.

Trelegy Ellipta = fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI).

A news item related to a study on this agent: "GlaxoSmithKline: IMPACT Study Shows Benefits Of Trelegy Ellipta In COPD Patients". AFX News. 19 April 2018. Retrieved 2018-04-20.

--User:Ceyockey (talk to me) 01:58, 21 April 2018 (UTC)[reply]

Anoro

[edit]

How can you get it without insurance and a reasonable price 74.69.156.226 (talk) 14:29, 27 October 2023 (UTC)[reply]